Frequently Asked Questions
The market is segmented based on Middle East and Africa Enteral Feeding Formula Market, By Product (Standard Formulas, Diabetic Formula, Renal Formula, Hepatic Formula, Pulmonary Formula, Peptide-based Formula, Other Disease Specific Formula, and Disease-Specific Formulas), Application (Oncology, Neurology, Critical Care, Diabetes, Gastroenterology, and Others), Type of Tube Feeding (Gastric Tube Feeding, Nasogastric Tube Feeding, Gastrostomy Tube Feeding, and Duodenal or Jejunal Tube Feeding), Stage (Adult and Pediatric), End User (Hospitals, Nursing Homes, Assisted Living Facilities, Home Care Agencies, and Hospices and Long Term Care Facilities) – Industry Trends and Forecast to 2030.
.
The Middle East Africa Enteral Feeding Formula Market size was valued at USD 0.58 USD Billion in 2022.
The Middle East Africa Enteral Feeding Formula Market is projected to grow at a CAGR of 7.3% during the forecast period of 2023 to 2030.
The major players operating in the market include , Nutricia , Hormel Foods Corporation , Medline Industries , Mead Johnson & Company LLC. , Nestlé Health Science , Abbott , Meiji Holdings Co. , Fresenius Kabi AG , B. Braun SE , Trovita Health Science , Victus , Avanos Medical , Cardinal Health , Moog , , Conmed Corporation , Cook Medical .
The market report covers data from the Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
